Clinical development and potential of photothermal and photodynamic therapies for cancer

Keywords

Photothermal therapyPhotodynamic therapyMedicinePhotosensitizerCancerCancer therapyAdverse effectCancer treatmentTumor ablationTreatment modalityCancer researchNanotechnologyPharmacologyAblationInternal medicine

Affiliated Institutions

Related Publications

Development of a Companion Diagnostic PD-L1 Immunohistochemistry Assay for Pembrolizumab Therapy in Non–Small-cell Lung Cancer

Charlotte Roach , Nancy Zhang , Ellie Corigliano +7 more

A companion diagnostic assay was codeveloped by Dako for pembrolizumab non–small-cell lung cancer clinical trials to detect PD-L1 expression by immunohistochemistry (IHC). This ...

2016 Applied immunohistochemistry & molecu... 346 citations

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Martin Reck , Delvys Rodríguez‐Abreu , Andrew Robinson +15 more

In patients with advanced NSCLC and PD-L1 expression on at least 50% of tumor cells, pembrolizumab was associated with significantly longer progression-free and overall survival...

2016 New England Journal of Medicine 9645 citations

Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.

Takashi Sakakibara , Yan Xu , Harvey L. Bumpers +5 more

Further examination of the heterogeneous properties of primary human breast carcinomas within SCID mice may provide a simple yet valuable new approach for the long-term study of...

2006 PubMed 42 citations

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study

Rita Nanda , Laura Q.M. Chow , Elizabeth Claire Dees +9 more

Purpose Immune checkpoint inhibition has been demonstrated to be an effective anticancer strategy. Several lines of evidence support the study of immunotherapy in triple-negativ...

2016 Journal of Clinical Oncology 1427 citations

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian , F. Stephen Hodi , Julie R. Brahmer +27 more

Anti-PD-1 antibody produced objective responses in approximately one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse...

2012 New England Journal of Medicine 12335 citations

Publication Info

Year: 2020
Type: review
Volume: 17
Issue: 11
Pages: 657-674
Citations: 3068
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Clinical development and potential of photothermal and photodynamic therapies for cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

3068

OpenAlex

Cite This

APA Style

                            
                                
                                    Xingshu Li, 
                                
                                    Jonathan F. Lovell, 
                                
                                    Juyoung Yoon
                                
                                et al.
                            
                            (2020). 
                            Clinical development and potential of photothermal and photodynamic therapies for cancer. 
                            Nature Reviews Clinical Oncology
                            , 17
                            (11)
                            , 657-674.
                            https://doi.org/10.1038/s41571-020-0410-2
                        

Identifiers

DOI: 10.1038/s41571-020-0410-2